Survey of Ophthalmology
Volume 55, Issue 5 , Pages 460-466 , September 2010

Multiple Sclerosis on Steroids

  • Matthew S. Johnson, MD

      Affiliations

    • Departments of Ophthalmology, Neurology, and Neurosurgery, University of Minnesota, Minneapolis, Minnesota, USA
    • ,
  • Michael S. Lee, MD

      Affiliations

    • Departments of Ophthalmology, Neurology, and Neurosurgery, University of Minnesota, Minneapolis, Minnesota, USA
    • Corresponding Author InformationReprint address: Michael S. Lee, MD, 420 Delaware St SE, MMC 493, Minneapolis, MN 55455.
    • ,
  • Brian R. Younge, MD

      Affiliations

    • Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA
    • ,
  • Valerie Purvin, MD

      Affiliations

    • Indiana University Medical Center and Midwest Eye Institute, Indianapolis, Indiana, USA

References 

  1. Bitsch AC, Wegener C, Da Costa S, et al. Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination. Multiple Sclerosis. 1999;5:138–146
  2. Canellas AR, Gols AR, Izquierdo JR, et al. Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology. 2007;49:393–409
  3. Capello E, Mancardi GL. Marburg type and Balo's concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol Sci. 2004;25:S361–S363
  4. Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology. 1996;38:560–565
  5. Danesh-Meyer HV, Levin LA. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?. Br J Ophthalmol. 2007;91:1551–1555
  6. Danesh-Meyer HV, Savino PJ, Biluk JR, et al. Aggressive glioma of adulthood simulating ischemic optic neuropathy. Arch Ophthalmol. 2005;123:694–700
  7. Lee AG, Eggenberger ER, Kaufman DI, et al. Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J NeuroOphthalmol. 1999;19:235–237
  8. Fukazawa T, Kikuchi S. A three-dimensional approach for understanding the spectrum of idiopathic inflammatory demyelinating disorders: importance of the ‘attack-related severity’ axis. Multiple Sclerosis. 2007;13:199–207
  9. Fukazawa T, Kikuchi S, Niino M, et al. Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders. J Neurol Sci. 2004;225:71–78
  10. Greven CM, Singh T, Stanton CA, et al. Optic chiasm, optic nerve, and retinal involvement secondary to varicella zoster virus. Arch Ophthalmol. 2001;119:608–610
  11. Haupts MR, Schimrigk S, Chan A, et al. Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology. J Neurol. 2008;255:1272–1273
  12. Johnson MD, Lavin P, Whetsell WO. Fulminant monophasic multiple sclerosis, Marburg's type. J Neurol Neurosurg Psychiat. 1990;53:918–921
  13. Keltner JL, Johnson CA, Spurr JO, et al. and the Optic Neuritis Study Group Baseline visual field profile of optic neuritis: the experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1993;111:231–234
  14. Miller D, McDonald I, Smith K. The diagnosis of multiple sclerosis. In:  Confavreaux C,  Lassmann H,  McDonald I, et al. editor. McAlpine's Multiple Sclerosis. ed 4. Philadelphia: Churchill Livingstone; 2005;p. 347–388
  15. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple Sclerosis. New Engl J Med. 2000;343:938–952
  16. Pershing S, Dunn J, Khan A, et al. Cytomegalovirus infection with MRI signal abnormalities affecting the optic nerves, optic chiasm and optic tracts. J Neuro-Ophthalmol. 2009;29:223–226
  17. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63:390–396
  18. Poser CM, Brinar VV. The nature of multiple sclerosis. Clin Neurol Neurosurg. 2004;106:159–171
  19. Rizzo JF, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmol. 2002;109:1679–1684
  20. Rodriguez M, Karnes WE, Bartleson JD, et al. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology. 1993;43:1100–1104
  21. Tumialan LM, Dhall SS, Biousse V, et al. Optic nerve glioma and optic neuritis mimicking one another: case report. Neurosurgery. 2005;57:E190
  22. Vaphiades MS. Optic nerve enhancement in hypotensive ischemic optic neuropathy. J Neuro-Ophthalmol. 2004;24:235–236
  23. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. Brain. 1989;112:133–146
  24. Wingerchuk DM, Hogancamp WR, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53:1107–1114

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. Dr. Lee received an unrestricted grant from Research to Prevent Blindness, New York, NY, and the Lions Club of Minnesota.

PII: S0039-6257(09)00305-1

doi: 10.1016/j.survophthal.2009.11.002

Survey of Ophthalmology
Volume 55, Issue 5 , Pages 460-466 , September 2010

Article Tools

* Image Usage & Resolution